Videos

At the 2023 World Congress on Gastrointestinal Cancers, Josep Tabernero, MD, PhD presented a post hoc analysis of the BEACON trial that evaluated differences among patients with BRAF V600E-mutant metastatic colorectal cancer treated with...

At the 2023 World Congress on Gastrointestinal Cancers, Thierry André, MD, discussed the use of checkpoint inhibitors for patients with MSI-high colorectal cancer.

At the 2023 World Congress on Gastrointestinal Cancers, Sabine Tejpar, MD, PhD, explained the application of single cell analyses in colorectal cancer.

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Evens, DO, MBA, MSc, discusses current treatment options for patients with Hodgkin lymphoma after relapse occurs.

Monique Hartley-Brown, MD, MMSc, presents her insights into treatment developments for patients with relapsed/refractory multiple myeloma, a topic which she discussed at the 2023 Great Debates & Updates in Hematologic Malignancies meeting.

At the 2023 World Congress on Gastrointesinal Cancers, Matti Aapro, MD, discusses how to best address emesis among patients with gastrointestinal cancers.

At the 2023 World Congress on Gastrointestinal Cancers, Guillen Argiles, MD, discussed the mechanisms of response to immune checkpoint inhibitors in colorectal cancer.

At the 2023 World Congress on Gastrointestinal Cancers, Erika Martinelli, MD, PhD, highlighted key upcoming advancements for the treatment of BRAF-mutant metastatic colorectal cancer.

At the 2023 World Congress on Gastrointestinal Cancers, Alberto Sobrero, MD, highlighted key advancements in colorectal cancer from the past 25 years.

At the 2023 World Congress on Gastrointestinal Cancers, Zev Wainberg, MD, presented results from the final analysis of the phase 2 FIGHT trial.